Question 1

Is Barinthus Biotherapeutics Plc BRNS stock halal to invest in?

Accepted Answer

No. As of February 2026, Barinthus Biotherapeutics (BRNS) does not pass AAOIFI Shariah screening because interest-bearing investments exceeds the permitted limits. AAOIFI Standard No. 21 caps non-permissible income at 5% of revenue, and interest-bearing debt and investments at 30% of market capitalisation each. We re-screen monthly, so the status can change. Check the live verdict in the Tabadulat app.

Question 2

How often is Barinthus Biotherapeutics Plc BRNS reviewed for Shariah compliance?

Accepted Answer

Tabadulat re-screens Barinthus Biotherapeutics (BRNS) every month. Each review applies AAOIFI Shariah Standard No. 21 to the latest financial data: business activity, non-permissible income, interest-bearing investments and debt, and preference shares. Our Shariah Supervisory Board oversees the process. Ratios move with the market, so a verdict can change. App users are alerted if a holding turns non-compliant.

Question 3

Does Barinthus Biotherapeutics Plc BRNS pass the AAOIFI Non Permissible Income criteria?

Accepted Answer

Yes. Barinthus Biotherapeutics's income from non-permissible sources stays below AAOIFI's 5% ceiling in the February 2026 screening. The screen covers interest, conventional finance, alcohol, gambling and tobacco. Small incidental amounts are allowed, but they must be purified: investors donate that share of dividends to charity. We re-check this screen every month.

Question 4

Does Barinthus Biotherapeutics Plc BRNS pass the AAOIFI Interest Bearing Investments criteria?

Accepted Answer

No. In the February 2026 screening, Barinthus Biotherapeutics's interest-bearing investments are above AAOIFI's 30% market-capitalisation limit, so this screen currently fails. The ratio moves with the share price as well as the balance sheet. We re-screen every month, and the result can change.

Question 5

Does STOCK  pass the AAOIFI Interest Bearing Debt criteria?

Accepted Answer

Yes. Barinthus Biotherapeutics's interest-bearing debt stays below 30% of market capitalisation in the February 2026 screening, inside the AAOIFI limit. The cap limits shareholders' exposure to interest-based leverage. Because market capitalisation changes daily, the ratio can drift without any new borrowing. We re-screen every month.

Question 6

How can I check the latest Shariah compliance status of Barinthus Biotherapeutics Plc stock?

Accepted Answer

No purification factor applies to Barinthus Biotherapeutics (BRNS) right now. Factors are published only for stocks that pass AAOIFI screening, and BRNS currently does not. Purification (Tazkiyah) means donating the small impure share of dividend income to charity. If BRNS returns to compliance in a monthly review, its factor is published again.

Question 7

Can the Shariah compliance status of Barinthus Biotherapeutics Plc stock change?

Accepted Answer

Yes. Barinthus Biotherapeutics has no impermissible preference share structure, so it passes this AAOIFI screen as of February 2026. Preference shares promise holders fixed or priority dividends ahead of ordinary shareholders. That conflicts with the Shariah principle of sharing profit and loss in proportion to ownership. The screen is verified in every monthly review.

Is Barinthus Biotherapeutics (BRNS) stock Halal?

Frequently asked questions